Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma
This research screened a library of drug-like molecules for activity against five causative agents of eumycetoma, a neglected fungal disease. Four compounds (fenbendazole, carbendazim, tafenoquine, and MMV1578570) inhibited all five species in vitro, and four (fenbendazole, MMV1782387, ravuconazole, and olorofim) prolonged survival in an infected insect model. Benzimidazole carbamates, a class including fenbendazole and carbendazim, emerged as particularly promising candidates.